Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.19
-0.32 (-3.42%)
At close: Apr 29, 2026, 4:00 PM EDT
9.19
0.00 (0.05%)
After-hours: Apr 29, 2026, 4:00 PM EDT
Upstream Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -143.44 | -62.81 | -20.54 | -23.87 |
| Depreciation & Amortization | 0.19 | 0.09 | 0.06 | 0.01 |
| Loss (Gain) From Sale of Investments | -1.5 | -1.66 | -1.26 | - |
| Stock-Based Compensation | 10.33 | 6 | 3.43 | 1.28 |
| Other Operating Activities | 0.56 | -2.68 | -15.31 | 0.15 |
| Change in Accounts Receivable | -0.06 | -0.52 | 0.31 | -0.41 |
| Change in Accounts Payable | -1.28 | 2.02 | 1.28 | 0.46 |
| Change in Other Net Operating Assets | 1.93 | 0.37 | -5.9 | 3.36 |
| Operating Cash Flow | -133.28 | -59.17 | -37.93 | -19.02 |
| Capital Expenditures | -0.17 | -0.51 | -0.14 | -0.08 |
| Investment in Securities | -93.32 | -58.97 | -82.7 | - |
| Investing Cash Flow | -93.48 | -59.49 | -82.84 | -0.08 |
| Issuance of Common Stock | 2.48 | 272.88 | 0.12 | - |
| Other Financing Activities | -0.03 | -3.97 | - | -0.04 |
| Financing Cash Flow | 2.44 | 418.91 | 129.55 | 9.96 |
| Net Cash Flow | -224.31 | 300.25 | 8.78 | -9.14 |
| Free Cash Flow | -133.44 | -59.68 | -38.07 | -19.1 |
| Free Cash Flow Margin | -4675.54% | -2518.27% | -1599.58% | -1576.15% |
| Free Cash Flow Per Share | -2.48 | -4.36 | -12.89 | -6.82 |
| Levered Free Cash Flow | -88.75 | -40.98 | -25.96 | - |
| Unlevered Free Cash Flow | -88.75 | -40.98 | -25.96 | - |
| Change in Working Capital | 0.59 | 1.87 | -4.31 | 3.41 |
Source: S&P Capital IQ. Standard template.
Financial Sources.